N/A
Completed N=14
Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)
Source: ClinicalTrials.gov NCT00940537 ↗Enrolled (actual)
14
Serious AEs
0.0%
Results posted
May 2010
Primary outcomePrimary: The Reproducibility of the Hepatic Triglyceride Content Measurement by MRS. — 13.0; 23.5; 4.4; 9.7 coefficient of variation
Summary
The purpose of this study is to see how effective the investigators' optimized magnetic resonance spectroscopy (MRS) sequence in quantifying hepatic triglyceride content (HTGC) to enhance MRS as a diagnostic tool in non-alcohol fatty liver disease (NAFLD).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Reproducibility of the Hepatic Triglyceride Content Measurement by MRS. |
13.0; 23.5; 4.4; 9.7 | — |
| SECONDARY The Hepatic Triglyceride Content Pre- and Post-prandial. |
30; 8; 27; 8 | .097 |
| SECONDARY T2 (Spin-spin Relaxation Time) Ratios of Triglyceride/Water |
0.9; 1.1; 1.1 | 0.006 sig |
Eligibility Criteria
Inclusion Criteria
- Obese
Exclusion Criteria
- Diabetes
- Pregnant
Data sourced from ClinicalTrials.gov (NCT00940537). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.